GL1X · GenesisL1 explorer

MolNFT v2 · #62284 · protein

3EAY: Crystal structure of the human SENP7 catalytic domain

3EAY · Sentrin-specific protease 7: “Crystal structure of the human SENP7 catalytic domain”. X-ray diffraction at 2.4, 1 ligand (SO4), 2 pockets (best druggability 0.41). MolNFT v2 #62284 on GenesisL1: 3D structure, binding sites and…

3D structure of 3EAY: Crystal structure of the human SENP7 catalytic domain (MolNFT v2 / PDB Bank)
3D structure of 3EAY: Crystal structure of the human SENP7 catalytic domain (MolNFT v2 / PDB Bank)
PDB
3EAY
Type
protein
Length
247 residues
Chains
1
Method
x-ray diffraction
Authors
Lima, C.D., Reverter, D.
Deposited
08/26/08
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.4
Source
Homo sapiens
Molecule
Sentrin-specific protease 7
EC
3.4.22.-
UniProt
Q9BQF6
Ligands
SO4
Pockets
2 · best druggability 0.41

Structure

x-ray diffraction · resolution 2.4 · 1 distinct chain · 40% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASentrin-specific protease 7 (EC 3.4.22.-)protein24740% helix, 16% strandQ9BQF6

Ligands and binding sites

  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11190.410.7515empty
2650.290.7319empty

Compared structures

  • 3EAY · Crystal structure of the human SENP7 catalytic domain · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9BQF6 · AlphaFold monomer V2.0 prediction for sentrin-specific protease 7 (Q9BQF6) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

Other records of 3EAY

  • 3EAY-2 · MolNFT v1 / PDB · Crystal structure of the human SENP7 catalytic domain

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.